THANGAMAYL.NS(THANGAMAYL.NS)
THANGAMAYL.NS
No analyst ratings available
No analyst price targets available for THANGAMAYL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $120.40B | $147.59B | $165.51B |
| Low | $109.03B | $132.88B | $152.04B |
| High | $130.66B | $156.76B | $178.97B |
| EBITDA Avg | $6.13B | $7.51B | $8.42B |
| Low | $5.55B | $6.76B | $7.74B |
| High | $6.65B | $7.98B | $9.11B |
| EBIT Avg | $5.58B | $6.85B | $7.68B |
| Low | $5.06B | $6.16B | $7.05B |
| High | $6.06B | $7.27B | $8.30B |
| Net Income Avg | $4.30B | $5.93B | $6.98B |
| Low | $4.18B | $5.70B | $6.79B |
| High | $4.41B | $6.16B | $7.17B |
| EPS Avg | $137.17 | $190.90 | $224.50 |
| Low | $134.59 | $183.25 | $218.41 |
| High | $141.81 | $198.18 | $230.59 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $26.74B | $30.74B | $32.07B |
| Low | $26.74B | $30.74B | $32.07B |
| High | $26.74B | $30.74B | $32.07B |
| EBITDA Avg | $1.36B | $1.56B | $1.63B |
| Low | $1.36B | $1.56B | $1.63B |
| High | $1.36B | $1.56B | $1.63B |
| EBIT Avg | $1.24B | $1.43B | $1.49B |
| Low | $1.24B | $1.43B | $1.49B |
| High | $1.24B | $1.43B | $1.49B |
| Net Income Avg | $824M | $1.20B | $1.31B |
| Low | $824M | $1.20B | $1.31B |
| High | $824M | $1.20B | $1.31B |
| EPS Avg | $26.50 | $38.70 | $42.00 |
| Low | $26.50 | $38.70 | $42.00 |
| High | $26.50 | $38.70 | $42.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |